title: [Study on personality and psychiatric disorder in fibromyalgia].
abstract: WORK INTEREST: To assess vulnerability factors of outpatients with fibromyalgia, by the evaluating prevalence of DSM-IV axis I disorders (mental disorders) and axis II disorders (personality disorders).
  
  
  METHODS
  30 outpatients with fibromyalgia were examined consecutively, and were administered the Mini International Neuropsychiatric Interview and the Structured Clinical Interview for DSM-IV.
  
  
  RESULTS
  The patients were found to have a high prevalence of DSM-IV axis I disorders (63,3% received a diagnosis of depressive and/or anxious disorder), and axis II disorders (46,7% received at least one diagnosis of personality disorder, including obsessive-compulsive personality disorder: 30%, borderline personality disorder: 16,7%, and depressive personality disorder: 16,7%).
  
  
  CONCLUSIONS
  Our results show the importance of psychiatric comorbidities, including personality disorders from outpatients with fibromyalgia. Personality disorders have to be taken into account in the treatment by their impact on doctor-patient relation. Our results suggest the importance of liaison psychiatry in the treatment of those patients.
authors.affiliation: Université Lille 2, CHRU de LILLE, Service d'Addictologie, F-59037 LILLE, France.
authors.forename: Sébastien
authors.initials: S
authors.lastname: Rose
authors.forename: Olivier
authors.initials: O
authors.lastname: Cottencin
authors.forename: Vincent
authors.initials: V
authors.lastname: Chouraki
authors.forename: Jean-Michel
authors.initials: JM
authors.lastname: Wattier
authors.forename: Eric
authors.initials: E
authors.lastname: Houvenagel
authors.forename: Benoit
authors.initials: B
authors.lastname: Vallet
authors.forename: Michel
authors.initials: M
authors.lastname: Goudemand
mesh_terms: D015897:Comorbidity; D004363:Drug Utilization; D005260:Female; D005356:Fibromyalgia / Q000150:complications / Q000523:psychology*; D006801:Humans; D007406:Interview, Psychological; D008297:Male; D001523:Mental Disorders / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D008875:Middle Aged; D011619:Psychotropic Drugs / Q000627:therapeutic use
chemical_list: D011619:Psychotropic Drugs